The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
c1XBHGaKzATL5UAM
Listen
